Xpention Genetics, Inc. Signs Research Agreement With Colorado State University
10/19/2005 5:13:20 PM
CONIFER, CO -- (MARKET WIRE) -- 10/10/2005 -- Xpention Genetics, Inc. (OTC BB: XPNG) and Colorado State University sign agreement for collaboration in the development of an immunological diagnostic cancer test for use on canines. The agreement calls for Colorado State University College of Veterinary Medicine and Biomedical Sciences to provide blood and tissue specimens from canine cancer subjects as well as a small number of normal dogs that Xpention will use in clinical trials for development of its canine cancer detection test utilizing p65 technology licensed by Xpention Inc., a wholly owned subsidiary of Xpention Genetics, Inc. from The University of Texas M. D. Anderson Cancer Center.
comments powered by